1 Improving the prevention and early detection
of cancer
1. Rates of cancer incidence are increasing across
the developed world. Between 1971 and 2000 total cancer incidence
increased by 21% for men and 39% for women (Figure 1).
The pattern varies among the major cancers. Incidence has increased
sharply for breast and prostate cancer, much more slowly for bowel
cancer and fallen sharply for lung cancer among men, but not women.
There are a number of causes underlying this, in particular the
ageing population, though the reasons for increases in some cancers
are not fully understood. Nevertheless, it is estimated that up
to two thirds of cancers are preventable.[2]
Figure 1:
Changes in cancer incidence and mortality rates in the last 30
years
2. During the same period mortality fell by 18% for
men and 7% for women (Figure 1). For men, the large fall is attributable
to a sharp decline in cases of lung cancer. For women, falls in
breast and bowel cancer mortality have been partially offset by
increases in lung cancer mortality.
3. Despite the fall in lung cancer incidence, smoking
remains the largest single factor influencing the overall level
of cancer incidence and mortality.[3]
In measuring the success of its Stop Smoking programme, the Department
considers that a person has successfully quit smoking if they
abstain for four weeks. The long-term effectiveness of these measures
is less clear, since it is estimated that only about 30% of people
quitting will still not be smoking 12 months later. There is a
seven-fold variation in the proportion of quitters between the
Strategic Health Authorities with the largest and smallest numbers
of quitters.[4]
4. English survival rates from cancer are still well
below the best in Europe, especially for people in deprived areas
of England. A key factor is the tendency of some patients,
especially the old and those from deprived areas, to be diagnosed
at a later stage of the disease.[5]
There are several contributory factors to this later diagnosis.
No one knows how much each factor contributes to delays:
- Delay in patient awareness.
In the NHS Cancer Plan in 2000 the Department undertook to develop
a comprehensive cancer public awareness programme, which is still
awaited.[6] Awareness of
symptoms remains low among the population at large, despite the
success of particular targeted campaigns.[7]
- Delay in patient coming forward with symptoms.
The Department has commissioned several pieces of research to
investigate the reasons why patients with symptoms delay consulting
their GPs.[8] This research,
due to be published shortly, will form the basis for strategies
to promote awareness.[9]
- Delay in onward referral from GPs.
It is not known to what extent GPs' failure to identify cancer
symptoms early contributes to poor outcomes. Half of GPs responding
to the NAO survey were not finding existing guidance helpful.
They frequently seemed to think guidance was not necessary,[10]
revealing a complacency evidenced by the large numbers of cancer
sufferers not initially referred urgently by GPs. Patients referred
urgently by GPs are now almost always seen by specialists within
2 weeks but those that are not (one third or more of patients
subsequently diagnosed with cancer) can take several months to
be seen by a specialist.[11]
- Delay in carrying out diagnostic tests.
Delays in carrying out vital diagnostic tests in radiology, endoscopy
and pathology are common throughout England, but are difficult
to quantify because this information is not collected in a standardised
format on a day-to-day basis by the NHS.[12]
The NHS is greatly expanding training facilities and increasing
efforts to recruit staff in these areas, partly by restructuring
services to widen access to these specialisms. However, in recent
years vacancies for radiographers and pathologists have continued
to rise.[13]
2 Q 75 Back
3
Qq 2, 68, 72 Back
4
C&AG's Report, paras 2.8-2.9; Q 50 Back
5
C&AG's Report, para 2.27 Back
6
Qq 3-8 Back
7
C&AG's Report, paras 2.30-2.32 Back
8
Qq 67, 73-74 Back
9
Q 82 Back
10
C&AG's Report, para 2.35; Q 161 Back
11
C&AG's Report, paras 2.41-2.42; Qq 160, 162, 164 Back
12
Qq 105-106 Back
13
C&AG's Report, paras 2.45, 2.55 Back
|